Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: Results of the phase 3 ARCON trial

European Journal of Cancer

Volumn 50, Issue 6, 2014, Pages 1112-1119

  Janssens, Geert O ^a   Van Bockel, Liselotte W ^b   Doornaert, Patricia A ^c   Bijl, Hendrik P ^d   Van Den Ende, Piet ^e   De Jong, Martin A ^f   Van Den Broek, Guido B ^a   Verbist, Berit M ^a   Terhaard, Chris H ^b   Span, Paul N ^a   Kaanders, Johannes H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ARCON; Laryngeal cancer; Lymph node volume; Randomised trial; Tumour volume

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOGEN; NICOTINAMIDE;

ARTICLE; CANCER CONTROL; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; KAPLAN MEIER METHOD; LARYNX CANCER; LARYNX TUMOR; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION ONCOLOGIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; TUMOR VOLUME;

ARCON; LARYNGEAL CANCER; LYMPH NODE VOLUME; RANDOMISED TRIAL; TUMOUR VOLUME;

CARBON DIOXIDE; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NIACINAMIDE; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN; PROGNOSIS; RADIATION-SENSITIZING AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84897049659     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.12.012     Document Type: Article

References (34)

1. G.B. Van den Broek, C.R. Rasch, and F.A. Pameijer et al. Pretreatment probability model for predicting outcome after intra-arterial chemoradiation for advanced head and neck carcinoma Cancer 101 2004 1809 1817
2. G. Studer, U.M. Lutolf, M. El-Bassiouni, V. Rousson, and C. Glanzmann Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT Acta Oncol 46 2007 386 394
3. R. Ljumanovic, J.A. Langendijk, and B. Schenk et al. Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging Radiology 232 2004 440 448
4. R. Ljumanovic, J.A. Langendijk, and M. van Wattingen et al. MR Imaging predictors of local control of glottic squamous cell carcinoma treated with radiation alone Radiology 244 2007 205 212
5. W.R. Lee, A.A. Mancuso, E.M. Saleh, W.M. Mendenhall, J.T. Parsons, and R.R. Million Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone Int J Radiat Oncol Biol Phys 25 1993 683 687
6. F.A. Pameijer, A.A. Mancuso, W.M. Mendenhall, J.T. Parsons, and P.S. Kubilis Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 37 1997 1011 1021
7. W.M. Mendenhall, J.T. Parsons, A.A. Mancuso, F.A. Pameijer, S.P. Stringer, and N. Cassisi Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx J Clin Oncol 15 1997 2394 2402
8. A.A. Mancuso, S.K. Mukherji, and I. Schmalfuss et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma J Clin Oncol 17 1999 631 637
9. W.M. Mendenhall, C.G. Morris, R.J. Amdur, R.W. Hinerman, and A.A. Mancuso Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck Head Neck 25 2003 535 542
10. W.M. Mendenhall, R.R. Million, and F.J. Bova Analysis of time-dose factors in clinically positive neck nodes treated with radiation alone in squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 10 1984 639 643
11. J.P. Bataini, J. Bernier, and B. Asselain et al. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modeling system to predict the radiocurability of neck nodes Int J Radiat Oncol Biol Phys 14 1988 635 642
12. J.M. Taylor, W.M. Mendenhall, and R.S. Lavey Time-dose factors in positive neck nodes treated with irradiation only Radiother Oncol 22 1991 167 173
13. S.W. Chen, S.N. Yang, J.A. Liang, F.J. Lin, and M.H. Tsai Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy Head Neck 31 2009 709 716
14. M.R. Vergeer, P. Doornaert, C.R. Leemans, J. Buter, B.J. Slotman, and A.J. Langendijk Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation Radiother Oncol 79 2006 39 44
15. Y.A. Tsou, J.H. Hua, M.H. Lin, and M.H. Tsai Analysis of prognostic factors of chemoradiation therapy for advanced hypoharyngeal cancer - does tumor volume correlate with central necrosis and tumor pathology? ORL J Otorhinolaryngol Relat Spec 68 2006 206 212
16. R. Hermans, W. van den Bogaert, A. Rijnders, and A.L. Baert Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy Int J Radiat Oncol Biol Phys 44 1999 755 765
17. G.O. Janssens, S.E. Rademakers, and C.H. Terhaard et al. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial J Clin Oncol 30 2012 1777 1782
18. G.O. Janssens, C.H. Terhaard, and P.A. Doornaert et al. Acute toxicity profile and compliance to ARCON for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial Int J Radiat Oncol Biol Phys 82 2012 532 538
19. J.M. Henk, P.B. Kunkler, and C.W. Smith Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial Lancet 2 1977 101 103
20. K. Haustermans, A.J. van der Kogel, B. Vanacker, and E. van der Schueren Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance Radiother Oncol 31 1994 123 128
21. J.H. Kaanders, J. Bussink, and A.J. van der Kogel ARCON: a novel biology-based approach in radiotherapy Lancet Oncol 3 2002 728 737
22. V. Gregoire, P. Levendag, and K.K. Ang et al. Ct-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines Radiother Oncol 69 2003 227 236
23. K.K. Fu, T.F. Pajak, and A. Trotti et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
24. J. Overgaard, H.S. Hansen, and L. Specht et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933 940
25. J. Bourhis, J. Overgaard, and H. Audry et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 2006 843 854
26. G.H. Fletcher, R.D. Lindberg, and R.H. Jesse Radiation therapy for cancer of the larynx and pyriform sinus Eye Ear Nose Throat Digest 31 1969 58 67
27. N.A. Ghossein, J.P. Bataini, A. Ennuyer, P. Stacey, and V. Krishnaswamy Local control and site of failure of in radically irradiated supraglottic laryngeal cancer Radiology 112 1974 187 192
28. A.S. Garden, K. Forster, P.F. Wong, W.H. Morrison, N.R. Schechter, and K.K. Ang Results of radiotherapy for T2N0 glottic carcinoma: does the "2"stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 55 2003 322 328
29. R.W. Hinerman, W.M. Mendenhall, R.J. Amdur, S.P. Stringer, D.B. Villaret, and K.T. Robbins Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with neck dissection Head Neck 24 2002 456 467
30. C.C. Wang, and W.W. Montgomery Deciding on optimal management of supraglottic carcinoma Oncology 5 1991 41 46
31. M. Soliman, A. Yaromina, and S. Appold et al. GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial Radiother Oncol 106 2013 299 304
32. W.L. Lodder, F.A. Pameijer, C.R. Rash, M.W. van den Brekel, and A.J. Balm Prognostic significance of radiologically determined neck node volume in head and neck cancer: a systematic review Oral Oncol 48 2012 298 302
33. T. Rieckmann, S. Tribius, and T.J. Grob et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiother Oncol 107 2013 242 246
34. E. Chow, D. Payne, T. Keane, T. Panzarella, and M.A. Izard Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 39 1997 149 154